12 - On the Cutting Edge of HIV Prevention

Debate Style Speaker(s)

• 

  Douglas Krakower, MD

  Assistant Professor of Medicine and Population Medicine
  Harvard Medical School
  Boston, Massachusetts

  Disclosure: DKBmed : Honoraria for developing medical education content (Status: Terminated --- 2019), Other Financial or Material Support (Status: Terminated --- 2019); Gilead Sciences : Consultant to Fenway Health for research funded by Gilead (Status: Terminated --- 2019), Other Financial or Material Support (Status: Terminated --- 2019); MED-IQ : Honoraria for developing medical education content (Status: Terminated --- 2017), Other Financial or Material Support (Status: Terminated --- 2017); Medscape : Honoraria for developing medical education content (Status: Terminated --- 2017), Other Financial or Material Support (Status: Terminated --- 2017); Merck : Grant/Research Support (Status: Ongoing); UpToDate. Inc : Other Financial or Material Support (Status: Ongoing), Royalties for developing medical education content (Status: Ongoing)
• 

  Susan Little, MD

  Prof.
  University of California, San Diego
  San Diego, CA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Annie Luetkemeyer, MD

  Professor of Medicine
  UCSF
  San Francisco, California

  Disclosure: Hologic : Donation of STD test kits for RCT of DoxyPEP (Status: Ongoing), Other Financial or Material Support (Status: Ongoing); Mayne Pharma : Donation of doxycycline for RCT (Status: Ongoing), Other Financial or Material Support (Status: Ongoing)
• 

  Greg Millett, MPH

  Director if Public Policy
  amfAR, DC

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-454-H02-P

Learning Objectives:

• assess the pros and cons of including antibiotics with PrEP for combined STI and HIV prophylaxis
• discuss the benefits and potential harms of using molecular surveillance to stop HIV outbreaks

Presentations:

• 3:45pm – 5:00pm EDT

  Antibiotics as STD Prophylaxis, in Addition to Prep - Reasonable Protection or Unnecessary Use
  Douglas Krakower, MD – Harvard Medical School
• 3:45pm – 5:00pm EDT

  Antibiotics as STD Prophylaxis, in Addition to Prep - Reasonable Protection or Unnecessary Use
  Annie Luetkemeyer, MD – UCSF
• 3:45pm – 5:00pm EDT

  Using Molecular Surveillance to Stop HIV Outbreaks
  Greg Millett, MPH – amfAR
• 3:45pm – 5:00pm EDT

  Using Molecular Surveillance to Stop HIV Outbreaks
  Susan J. Little, MD – University of California, San Diego